APPARATUS AND METHOD FOR STORING MEDICAL INFORMATION
    3.
    发明申请
    APPARATUS AND METHOD FOR STORING MEDICAL INFORMATION 有权
    用于存储医疗信息的装置和方法

    公开(公告)号:US20080201372A1

    公开(公告)日:2008-08-21

    申请号:US12032006

    申请日:2008-02-15

    IPC分类号: G06F17/30

    摘要: There are provided an input unit which inputs an object with scan information attached thereto into an image of a subject acquired on the basis of the scan information, and an insertion unit which inserts report information to the object when preparation of an image interpretation report of a study based on the image is completed.

    摘要翻译: 提供了一种输入单元,其将附加有扫描信息的对象输入到基于扫描信息获取的被摄体的图像;以及插入单元,其在准备图像解析报告时将该报告信息插入到对象 基于图像的学习完成。

    Report check apparatus and computer program product
    4.
    发明申请
    Report check apparatus and computer program product 有权
    报告检查仪器和计算机程序产品

    公开(公告)号:US20060241353A1

    公开(公告)日:2006-10-26

    申请号:US11396658

    申请日:2006-04-04

    IPC分类号: A61B5/00

    CPC分类号: G16H15/00 G06F19/00

    摘要: A report check apparatus includes an input unit which inputs data of a diagnostic reading report as a check target, a check unit which checks whether the input diagnostic reading report contains a semantic error related to diagnostic reading, and a display unit which displays a check result by the check unit.

    摘要翻译: 报告检查装置包括:输入单元,其输入作为检查对象的诊断读取报告的数据;检查单元,其检查输入诊断读取报告是否包含与诊断读取相关的语义错误;以及显示单元,其显示检查结果 由检查单位。

    Long-acting diclofenac sodium preparation
    5.
    发明授权
    Long-acting diclofenac sodium preparation 失效
    长效双氯芬酸钠制剂

    公开(公告)号:US4968505A

    公开(公告)日:1990-11-06

    申请号:US353016

    申请日:1989-05-17

    摘要: A long-acting diclofenac sodium preparation is disclosed. The preparation comprises a sustained-release diclofenac sodium component which is prepared by coating a sustained-release coat onto a pharmaceutical composition comprising diclofenac sodium and an organic acid. It can decrease the maximum blood concentration of diclofenac by suppressing and controlling the rate of release of diclofenac sodium and maintain the blood concentration of diclofenac constant for a considerably long period of time. The risk of side-effect occurrences is reduced and patients is released from frequent administration of the medicine.

    摘要翻译: 公开了一种长效双氯芬酸钠制剂。 该制剂包含持续释放的双氯芬酸钠组分,其通过将持续释放的涂层涂覆在包含双氯芬酸钠和有机酸的药物组合物上制备。 通过抑制和控制双氯芬酸钠的释放速度,可以降低双氯芬酸的最大血药浓度,并保持双氯芬酸的血药浓度持续相当长的一段时间。 副作用发生的风险降低,患者从药物的频繁使用中释放出来。

    Medical report producing apparatus, medical report referencing apparatus, and method for producing medical report
    6.
    发明授权
    Medical report producing apparatus, medical report referencing apparatus, and method for producing medical report 有权
    医疗报告生成装置,医疗报告参照装置以及医疗报告生成方法

    公开(公告)号:US07873526B2

    公开(公告)日:2011-01-18

    申请号:US11442333

    申请日:2006-05-30

    IPC分类号: G06Q10/00

    摘要: A link corresponding range is identified in a string in a finding section of a medical report display screen. A content is specified and dragged and dropped onto the area in which link corresponding range is displayed. When the string is specified, address information on the content is attached to the string. At the same time, the string in the link corresponding range is identified and displayed. The present apparatus subsequently determines whether or not to display information related to the linked reference content. If a display instruction has been given, a protocol that allows the related information to be automatically acquired and displayed is embedded in the hyperlink. When report production is completed, a file is saved to finish the series of processing operations. The file is then transferred to, for example, a trace reading report production requester.

    摘要翻译: 在医疗报告显示画面的查找部分中的字符串中识别链接对应范围。 指定内容并将其拖放到显示链接对应范围的区域。 当指定字符串时,内容上的地址信息被附加到字符串。 同时,链接对应范围中的字符串被识别并显示。 本装置随后确定是否显示与链接的参考内容有关的信息。 如果已经给出显示指令,则将自动获取和显示相关信息的协议嵌入到超链接中。 报表制作完成后,保存文件完成一系列处理操作。 然后将文件传输到例如跟踪阅读报告生产请求者。

    Oral preparations comprising S-(3-hydroxypropyl)-L-cysteine
    7.
    发明授权
    Oral preparations comprising S-(3-hydroxypropyl)-L-cysteine 有权
    包含S-(3-羟丙基)-L-半胱氨酸的口服制剂

    公开(公告)号:US06441040B1

    公开(公告)日:2002-08-27

    申请号:US09176155

    申请日:1998-10-21

    IPC分类号: A61K31195

    摘要: A preparation for oral administration which comprises S-(3-hydroxypropyl)-L-cysteine and one or more excipients, where the excipients do not cause discoloration of S-(3-hydroxypropyl)-L-cysteine is disclosled. According to an embodiment of the invention, the excipient may comprise a starch and/or a cyclodextrin. Typical starches used in the invention include corn starch, potato starch, wheat starch, and rice starch. Typical cyclodextrins used in the invention include &agr;-cyclodextrin, &bgr;-cyclodextrin, and &ggr;-cyclodextrin. Other excipients, such as saccharides, sugar alcohols and cellulose are not present in amounts that cause discoloration of the HPCY.

    摘要翻译: 公开了一种口服给药的制剂,其包含S-(3-羟丙基)-L-半胱氨酸和一种或多种赋形剂,其中赋形剂不引起S-(3-羟丙基)-L-半胱氨酸的变色。 根据本发明的一个实施方案,赋形剂可以包含淀粉和/或环糊精。 用于本发明的典型淀粉包括玉米淀粉,马铃薯淀粉,小麦淀粉和米淀粉。 用于本发明的典型环糊精包括α-环糊精,β-环糊精和γ-环糊精。 其它赋形剂,例如糖,糖醇和纤维素不以导致HPCY变色的量存在。

    Sustained release suppository
    8.
    发明授权
    Sustained release suppository 失效
    持续释放栓剂

    公开(公告)号:US5500221A

    公开(公告)日:1996-03-19

    申请号:US215970

    申请日:1994-03-18

    IPC分类号: A61K9/02 A61K9/14 A61K9/64

    摘要: The present invention relates to a sustained-release suppository preparation characterized by comprising an acidic drug or a salt thereof which can be absorbed by rectal administration and an acidic compound or a pH buffering agent. The sustained-release suppository preparation of the present invention exhibits no rapid increase in blood concentration immediately after the administration and maintains its action for a long period of time. Thus, it is safer and exhibits a better therapeutic effect.

    摘要翻译: 本发明涉及缓释栓剂制剂,其特征在于包含可通过直肠给药吸收的酸性药物或其盐,以及酸性化合物或pH缓冲剂。 本发明的持续释放栓剂制剂在施用后立即显示出血液浓度的迅速增加,并且长时间保持其作用。 因此,它更安全,具有更好的治疗效果。

    Antiinflammatory and analgesic gel preparation
    9.
    发明授权
    Antiinflammatory and analgesic gel preparation 失效
    抗炎止痛凝胶制剂

    公开(公告)号:US5422102A

    公开(公告)日:1995-06-06

    申请号:US109257

    申请日:1993-08-20

    摘要: An antiinflammatory and analgesic gel preparation comprising diclofenac or its salts, an ester of dibasic acid, a lower alcohol, and a nonionic polymer or a mixture of nonionic polymers selected from the group consisting of (a) 1.5-4% by weight of hydroxypropyl cellulose having a molecular weight of 500,000 or greater, (b) 2-4% by weight of hydroxyethyl cellulose having a molecular weight of 1,250,000 or greater, and (c) 1.5-4% by weight of a mixture of hydroxypropyl cellulose having a molecular weight of 500,000 or greater and hydroxyethyl cellulose having a molecular weight of 1,250,000 or greater, and having a viscosity of 5,000-35,000 cps and an yield value of 5 dyn/cm.sup.2 or greater. The gel preparation is excellent in the percutaneous absorption of diclofenac or its salts and provides good properties upon use and superior medical effects of diclofenac or its salts.

    摘要翻译: 包含双氯芬酸或其盐的抗炎和镇痛凝胶制剂,二元酸的酯,低级醇和非离子聚合物或非离子聚合物的混合物,其选自(a)1.5-4重量%的羟丙基纤维素 分子量为500,000以上,(b)2-4重量%的分子量为1,250,000以上的羟乙基纤维素,(c)1.5-4重量%的具有分子量的羟丙基纤维素的混合物 500,000以上的羟乙基纤维素和分子量为1,250,000以上的羟乙基纤维素,粘度为5,000〜35,000cps,屈服值为5dyn / cm 2以上。 凝胶制剂在双氯芬酸或其盐的经皮吸收方面是优异的,并且在使用时提供良好的性质和双氯芬酸或其盐的优异的医学效果。

    Composition for foaming preparation
    10.
    发明授权
    Composition for foaming preparation 失效
    发泡剂组合物

    公开(公告)号:US5204087A

    公开(公告)日:1993-04-20

    申请号:US806791

    申请日:1991-12-12

    IPC分类号: A61K9/00 A61K9/46

    CPC分类号: A61K9/0056 A61K9/0007

    摘要: A composition for foaming preparation comprising (a) an organic acid of which the crystal surface is coated with a sugar and (b) a carbonate is disclosed. In the composition, an organic acid is completely shut off from a carbonate by a sugar coating so that the acid does not react with the carbonate over a prolonged storage time. When the composition is put into mouth, the sugar which covers the acid is readily dissolved, allowing the acid and the carbonate to react and to generate carbon oxide gas. An excellent foaming calcium preparation can be produced by using calcium carbonate as the carbonate or by adding other salt of calcium to the composition. Such a calcium preparation gives a good taste and favorable feeling upon administration. It is especially suitable for regular administration of calcium over an extended period of time.

    摘要翻译: 公开了一种用于发泡制备的组合物,其包含(a)晶体表面被糖包覆的有机酸和(b)碳酸酯。 在组合物中,有机酸通过糖衣完全与碳酸盐隔绝,使得酸不会在延长的储存时间内与碳酸盐反应。 当组合物放入口中时,覆盖酸的糖容易溶解,使酸和碳酸酯反应并产生碳氧化物气体。 可以通过使用碳酸钙作为碳酸盐或通过向组合物中加入钙的其它盐来制备出色的起泡钙制剂。 这样的钙制剂在施用时具有良好的味道和良好的感觉。 特别适合于长时间钙的定期给药。